Liquid biopsy offers a less invasive method to detect resistance mechanisms by analyzing tumor DNA fragments in blood. Tissue biopsy, though more invasive, provides comprehensive insights into tumor ...

A liquid biopsy is a blood test designed to detect cancer cells or DNA fragments of cancer cells circulating in the ...

The best use of liquid biopsies in late-stage non–small cell lung cancer (NSCLC) will be to augment tissue biopsies at initial diagnosis and to evaluate patients for second- and third-line therapies.

Imperial researchers have used artificial intelligence (AI) to extract information about the chemical makeup of lung tumors from medical scans. For the first time, they have demonstrated how combining ...

A new lab assay developed by researchers at Fred Hutch Cancer Center could make diagnosis and treatment of small-cell lung cancer and non-small cell lung cancer easier. The work is published in the ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment. A study supported by ...

This investigation sprung from a lack of current knowledge on the impact of nonmalignant results following thoracic surgery for lung cancer, according to the authors. Of this patient population, all ...

People with cystic fibrosis (CF) face persistent threats from pathogens including Pseudomonas aeruginosa (Pa), which grow in the lung’s mucus-clogged environment. Detecting these infections early is ...

Ask a clinical question and tap into Healio AI's knowledge base. Lung cancer in general, and non-small cell lung cancer (NSCLC) in particular, is often asymptomatic in the early stages of the disease.